HOME >> BIOLOGY >> NEWS
Chemical derived from vitamin-E shows early promise as cancer drug

AUSTIN, Texas By studying cancer in mice, researchers at The University of Texas at Austin have gained preliminary evidence that a novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread to other body sites.

"We have clear evidence that this chemical is directly causing cancer cells to die," said Kimberly Kline, a nutrition professor in the Department of Human Ecology who directed the research in collaboration with Bob G. Sanders, a professor in the School of Biological Sciences.

The findings will be published in the October issue of Experimental Biology and Medicine. They result from studies involving treatment of genetically identical mice, which were given the novel vitamin E compound either orally or by aerosol.

Based on earlier, similar findings by Kline and colleagues, the National Cancer Institute is funding national efforts to investigate the ability of this novel compound, RRR-alpha-tocopherol ether acetic analog (alpha-TEA), to prevent colon and breast cancers in preclinical animal models.

Mice in the study were treated with alpha-TEA for 21 days after an injection of mouse-derived mammary cancer cells that normally would have formed a tumor mass and spread (metastasized) to the animals' lungs. Regardless of whether alpha-TEA was administered to the mice by mouth (orally) or via breathing (aerosol), the compound was capable of reducing the primary tumor mass by greater than half.

In addition, the compound was capable of reducing tumor lesions (metastases) in the lung that were big enough to see with the naked eye. For example, only one of 10 alpha-TEA aerosol-treated mice developed visible lung tumor lesions in comparison to five of 10 untreated control mice. None of the treated animals showed any type of general symptoms of toxicity to alpha-TEA, which Kline chose for further study in 1997 from 50 candidates.

Because cancer may result from
'"/>

Contact: Barbra Rodriguez
brodriguez@mail.utexas.edu
512-232-0675
University of Texas at Austin
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. Chemical genetics identifies SARS inhibitors
3. Chemical signals health of brain cells Symposium
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. Chemical engineers discover filtration system to help biotech industry
6. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
7. American Chemical Society media registration
8. Chemical Society announces EPA awards for environmentally friendly technology
9. NIH launches first center in Nationwide Chemical Genomics Network
10. Chemical reaction in birds provides sense of direction during migratory flights
11. Annual Chemical Biology Symposium at Yale May 14, 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... ... Board of Directors of Nanosens Innovations have each authorized the respective companies to ... a subsidiary of Cardea, with the Nanosens brand representing a series of products ...
(Date:8/27/2019)... ... ... Shoreline Biome , a microbiome research company that develops tools for characterizing ... and Karen Woodward as its VP of Business Development. , These two new ... expand the company’s sales worldwide. , Prior to joining Shoreline Biome, Bill McKenzie was ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar grape ... several Rochester Institute of Technology faculty and alumni sequenced the microbiome found within ...
Breaking Biology Technology:
Cached News: